These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1543536)

  • 1. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
    Weniger JP; Cate RL; Zeis A
    J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.
    Tsuji M; Shima H; Yonemura CY; Brody J; Donahoe PK; Cunha GR
    Endocrinology; 1992 Sep; 131(3):1481-8. PubMed ID: 1505479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antagonistic actions of testosterone and the anti-mullerian hormone on the mullerian duct of the chick embryo in culture in vitro].
    Weniger JP; Zeis A
    Arch Anat Microsc Morphol Exp; 1982; 71(2):99-106. PubMed ID: 6897160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative change in fibronectin in cultured müllerian mesenchymal cells in response to diethylstilbestrol and müllerian-inhibiting substance.
    Teng CS
    Dev Biol; 1990 Jul; 140(1):1-7. PubMed ID: 2358110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen inhibition of Mullerian inhibiting substance in the chick embryo.
    Hutson JM; Ikawa H; Donahoe PK
    J Pediatr Surg; 1982 Dec; 17(6):953-9. PubMed ID: 6897657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.
    MacLaughlin DT; Hudson PL; Graciano AL; Kenneally MK; Ragin RC; Manganaro TF; Donahoe PK
    Endocrinology; 1992 Jul; 131(1):291-6. PubMed ID: 1612008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.
    Meyers-Wallen VN; Lee MM; Manganaro TF; Kuroda T; Maclaughlin D; Donahoe PK
    Biol Reprod; 1993 Jun; 48(6):1410-8. PubMed ID: 8318594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid enhancement of Mullerian duct regression.
    Ikawa H; Hutson JM; Budzik GP; MacLaughlin DT; Donahoe PK
    J Pediatr Surg; 1982 Oct; 17(5):453-8. PubMed ID: 6897422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vivo roles of müllerian-inhibiting substance.
    Behringer RR
    Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Müllerian inhibiting substance is present in testes of dogs with persistent müllerian duct syndrome.
    Meyers-Wallen VN; Donahoe PK; Ueno S; Manganaro TF; Patterson DF
    Biol Reprod; 1989 Nov; 41(5):881-8. PubMed ID: 2576223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mullerian inhibiting substance: a fetal hormone with surgical implications.
    Hutson JM; Donahoe PK; Budzik GP
    Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid modulation of Mullerian duct regression in the chick embryo.
    Hutson JM; Donahoe PK; MacLaughlin DT
    Gen Comp Endocrinol; 1985 Jan; 57(1):88-102. PubMed ID: 3838289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of müllerian inhibiting substance in developing chick gonads by a competitive enzyme-linked immunosorbent assay.
    Teng CS
    Dev Biol; 1987 Sep; 123(1):255-63. PubMed ID: 3622932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ontogeny of Mullerian inhibiting substance in the gonads of the chicken.
    Hutson J; Ikawa H; Donahoe PK
    J Pediatr Surg; 1981 Dec; 16(6):822-7. PubMed ID: 6896069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic adenosine 3',5'-monophosphate modulation of mullerian duct regression.
    Ikawa H; Hutson JM; Budzik GP; Donahoe PK
    Endocrinology; 1984 May; 114(5):1686-91. PubMed ID: 6201348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.
    Wilson CA; di Clemente N; Ehrenfels C; Pepinsky RB; Josso N; Vigier B; Cate RL
    Mol Endocrinol; 1993 Feb; 7(2):247-57. PubMed ID: 8469238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen stimulation of nucleotide pyrophosphatase during mullerian duct regression.
    Fallat ME; Hutson JM; Budzik GP; Donahoe PK
    Endocrinology; 1984 May; 114(5):1592-8. PubMed ID: 6143657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Müllerian-inhibiting substance: an update.
    Donahoe PK; Budzik GP; Trelstad R; Mudgett-Hunter M; Fuller A; Hutson JM; Ikawa H; Hayashi A; MacLaughlin D
    Recent Prog Horm Res; 1982; 38():279-330. PubMed ID: 6896925
    [No Abstract]   [Full Text] [Related]  

  • 19. Paracrine-mediated apoptosis in reproductive tract development.
    Roberts LM; Hirokawa Y; Nachtigal MW; Ingraham HA
    Dev Biol; 1999 Apr; 208(1):110-22. PubMed ID: 10075845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Müllerian inhibiting substance in sex-reversed dogs.
    Meyers-Wallen VN; Donahoe PK; Manganaro T; Patterson DF
    Biol Reprod; 1987 Nov; 37(4):1015-22. PubMed ID: 3689844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.